← All organizations
Highest phase reached
Phase 2
First clinical trial
Aug 29, 2017Last known activity
Jun 24, 2022
Timeline
1960s
- Jun 1, 1964
Ludaopei Hospital— Founded
Drugs by trial phase (22 distinct, 32 trials)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (14 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Communicable Diseases
- Cytomegalovirus Infections
- Infections
- Leukemia
- Leukemia, B-Cell
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lymphoma
- Lymphoma, B-Cell
- Multiple Myeloma
- Neoplasm, Residual
- Neoplasms
- Neoplasms, Plasma Cell
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Virus Diseases
Recent trials (48)
- NCT05518357OfficialPhase 1Jun 24, 2022
- NCT05518357Overall official - principal investigatorPhase 1Jun 24, 2022
- NCT05225831OfficialEarly Phase 1Aug 15, 2021
- NCT05225831Overall official - principal investigatorEarly Phase 1Aug 15, 2021
- NCT04938115Overall official - principal investigatorN/AMay 10, 2021
- NCT04928105Overall official - principal investigatorN/AJan 27, 2021
- NCT04796441Overall official - principal investigatorN/ADec 16, 2020
- NCT04792593Overall official - principal investigatorN/ADec 3, 2020
- NCT04620655Sponsor investigatorN/ANov 15, 2020
- NCT04620655Overall official - principal investigatorN/ANov 15, 2020
- NCT04546893CollaboratorN/ASep 1, 2020
- NCT04546893Overall official - principal investigatorN/ASep 1, 2020
- NCT04546893CollaboratorN/ASep 1, 2020
- NCT04546906Overall official - principal investigatorN/ASep 1, 2020
- NCT04508842Lead sponsorPhase 1Aug 10, 2020
Details
- Founded
- Beijing, CN Jun 1, 1964
- Last known activity
- Jun 24, 2022